130 related articles for article (PubMed ID: 37747032)
1. The prognostic value of tumor-associated macrophages in glioma patients.
Shen Y; Zheng D; Hu D; Ma B; Cai C; Chen W; Zeng J; Luo J; Xiao D; Zhao Y; Wu Z; Jing G; Xie Y
Medicine (Baltimore); 2023 Sep; 102(38):e35298. PubMed ID: 37747032
[TBL] [Abstract][Full Text] [Related]
2. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
4. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.
Liu T; Zhu C; Chen X; Wu J; Guan G; Zou C; Shen S; Chen L; Cheng P; Cheng W; Wu A
Oncoimmunology; 2022; 11(1):2031499. PubMed ID: 35111386
[TBL] [Abstract][Full Text] [Related]
5. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J
Front Immunol; 2023; 14():1338244. PubMed ID: 38250074
[TBL] [Abstract][Full Text] [Related]
6. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
[No Abstract] [Full Text] [Related]
7. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
[TBL] [Abstract][Full Text] [Related]
8. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
Front Oncol; 2021; 11():611038. PubMed ID: 33937022
[TBL] [Abstract][Full Text] [Related]
9. The relationship between CD204
Kurdi M; Alghamdi B; Butt NS; Baeesa S
Discov Oncol; 2021 Aug; 12(1):28. PubMed ID: 35201470
[TBL] [Abstract][Full Text] [Related]
10. Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Chang SJ; Tu HP; Lai YC; Luo CW; Nejo T; Tanaka S; Chai CY; Kwan AL
Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32349342
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages related signature in glioma.
Wang LJ; Xue Y; Lou Y
Aging (Albany NY); 2022 Mar; 14(6):2720-2735. PubMed ID: 35332109
[TBL] [Abstract][Full Text] [Related]
12. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.
Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN
Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967
[No Abstract] [Full Text] [Related]
13. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
[TBL] [Abstract][Full Text] [Related]
14. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of TAMs marker genes in glioma for predicting prognosis and immunotherapy response.
Zhao Z; Wang Z; Wu Y; Liao D; Zhao B
Mol Immunol; 2022 Apr; 144():78-95. PubMed ID: 35203024
[TBL] [Abstract][Full Text] [Related]
16. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
17. LAG-3 expression in the inflammatory microenvironment of glioma.
Mair MJ; Kiesel B; Feldmann K; Widhalm G; Dieckmann K; Wöhrer A; Müllauer L; Preusser M; Berghoff AS
J Neurooncol; 2021 May; 152(3):533-539. PubMed ID: 33651248
[TBL] [Abstract][Full Text] [Related]
18. CD206
Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L
J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443
[TBL] [Abstract][Full Text] [Related]
19. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
Han S; Zhang C; Li Q; Dong J; Liu Y; Huang Y; Jiang T; Wu A
Br J Cancer; 2014 May; 110(10):2560-8. PubMed ID: 24691423
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.
Andersen JK; Miletic H; Hossain JA
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
